Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
Status:
Terminated
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
The primary aim of this trial is to compare the efficacy of mifepristone-misoprostol versus
misoprostol alone for treatment of intrauterine fetal demise between 14 and 28 weeks LMP.